Maravai Lifesciences logo

Maravai Lifesciences Share Price Today

(NASDAQ: MRVI)

Maravai Lifesciences share price is $1.77 & ₹151.27 as on 18 Apr 2025, 2.30 'hrs' IST

$1.77

0.05

(2.91%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Maravai Lifesciences share price in Dollar and Rupees. Guide to invest in Maravai Lifesciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Maravai Lifesciences, along with analyst recommendations, forecasts, and comprehensive financials.

Maravai Lifesciences share price movements

  • Today's Low: $1.67
    Today's High: $1.78

    Day's Volatility :6.18%

  • 52 Weeks Low: $1.67
    52 Weeks High: $11.56

    52 Weeks Volatility :85.59%

Maravai Lifesciences (MRVI) Returns

PeriodMaravai Lifesciences Holdings IncSector (Health Care)Index (Russel 2000)
3 Months
-66.16%
-2.8%
0.0%
6 Months
-79.18%
-11.0%
0.0%
1 Year
-75.75%
-1.9%
0.0%
3 Years
-95.03%
-1.5%
-12.9%

Maravai Lifesciences (MRVI) Key Statistics

in dollars & INR

Previous Close
$1.72
Open
$1.69
Today's High
$1.78
Today's Low
$1.67
Market Capitalization
$437.5M
Today's Volume
$2.2M
52 Week High
$11.555
52 Week Low
$1.665
Revenue TTM
$259.2M
EBITDA
$-24.3M
Earnings Per Share (EPS)
$-1.08
Profit Margin
-55.89%
Quarterly Earnings Growth YOY
-0.33%
Return On Equity TTM
-37.98%

How to invest in Maravai Lifesciences Stock (MRVI) from India?

It is very easy for Indian residents to invest directly in Maravai Lifesciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Maravai Lifesciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Maravai Lifesciences or MRVI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Maravai Lifesciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Maravai Lifesciences shares which would translate to 0.483 fractional shares of Maravai Lifesciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Maravai Lifesciences, in just a few clicks!

Returns in Maravai Lifesciences (MRVI) for Indian investors in Rupees

The Maravai Lifesciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Maravai Lifesciences investment value today

Current value as on today

₹26,588

Returns

₹73,412

(-73.41%)

Returns from Maravai Lifesciences Stock

₹75,753 (-75.75%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Maravai Lifesciences (MRVI)

-22%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Maravai Lifesciences Stock from India on INDmoney has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Maravai Lifesciences

  • GTCR LLC

    14.03%

  • Mackenzie Investments

    8.61%

  • Vanguard Group Inc

    8.23%

  • 12 West Capital Management LP

    8.07%

  • BlackRock Inc

    6.81%

  • BRAIDWELL LP

    5.82%

Analyst Recommendation on Maravai Lifesciences

Rating
Trend

Buy

    78%Buy

    21%Hold

    0%Sell

Based on 19 Wall street analysts offering stock ratings for Maravai Lifesciences(by analysts ranked 0 to 5 stars)

Analyst Forecast on Maravai Lifesciences Stock (MRVI)

What analysts predicted

Upside of 188.14%

Target:

$5.10

Current:

$1.77

Insights on Maravai Lifesciences Stock (Ticker Symbol: MRVI)

  • Price Movement

    In the last 7 days, MRVI stock has moved down by -6.0%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 73.4M → 56.40M (in $), with an average decrease of 12.3% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -99.03M → -26.14M (in $), with an average increase of 278.8% per quarter
  • MRVI vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 152.5%
  • MRVI vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 123.9%
  • Price to Sales

    ForMRVI every $1 of sales, investors are willing to pay $0.9, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Maravai Lifesciences Technicals Summary

Sell

Neutral

Buy

Maravai Lifesciences is currently in a neutral trading position according to technical analysis indicators.

Maravai Lifesciences (MRVI) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Maravai Lifesciences Holdings Inc logo
-28.33%
-79.18%
-75.75%
-95.03%
-95.34%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Maravai Lifesciences

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, and oligonucleotide therapy, as well as molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, CleanCap capping technology-based oligonucleotide building blocks, and custom enzyme development and manufacturing; and research products for labeling and detecting proteins in cells and tissue samples. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, and antibody-based products to detect impurities during the production of biopharmaceutical products. It serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was founded in 2014 and is headquartered in San Diego, California.
Organization
Maravai Lifesciences
Employees
570
CEO
Mr. William E. Martin III
Industry
Commercial Services

Management People of Maravai Lifesciences

NameTitle
Mr. William E. Martin III
CEO & Director
Mr. Kevin M. Herde CPA
Executive VP & CFO
Dr. Peter Michael Leddy Ph.D.
Executive VP & Chief Administrative Officer
Ms. Christine Dolan
Executive VP & GM of Cygnus Technologies
Ms. Debra Hart
Senior Director of Investor Relations
Mr. Kurt Oreshack J.D.
Executive VP, General Counsel & Secretary
Ms. Rebecca Buzzeo
Executive VP & Chief Commercial Officer
Dr. Kate E. Broderick Ph.D.
Executive VP & Chief Innovation Officer
Mr. Christopher C. Benoit
Executive VP & Advisor

Important FAQs about investing in MRVI Stock from India :

What is Maravai Lifesciences share price today?

Maravai Lifesciences share price today stands at $1.77, Open: $1.69 ; Previous Close: $1.72 ; High: $1.78 ; Low: $1.67 ; 52 Week High: $11.56 ; 52 Week Low: $1.67.

The stock opens at $1.69, after a previous close of $1.72. The stock reached a daily high of $1.78 and a low of $1.67, with a 52-week high of $11.56 and a 52-week low of $1.67.

Can Indians buy Maravai Lifesciences shares?

Yes, Indians can invest in the Maravai Lifesciences (MRVI) from India.

With INDmoney, you can buy Maravai Lifesciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Maravai Lifesciences at zero transaction cost.

How can I buy Maravai Lifesciences shares from India?

It is very easy to buy Maravai Lifesciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Maravai Lifesciences (MRVI) be purchased?

Yes, you can buy fractional shares of Maravai Lifesciences with INDmoney app.

What are the documents required to start investing in Maravai Lifesciences stocks?

To start investing in Maravai Lifesciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Maravai Lifesciences Stock (MRVI)?

Today’s highest price of Maravai Lifesciences (MRVI) is $1.78.

Today’s lowest price of Maravai Lifesciences (MRVI) is $1.67.

What is today's market capitalisation of Maravai Lifesciences?

Today's market capitalisation of Maravai Lifesciences MRVI is 437.5M

What is the 52 Week High and Low Range of Maravai Lifesciences Stock (MRVI)?

  • 52 Week High

    $11.56

  • 52 Week Low

    $1.67

What are the historical returns of Maravai Lifesciences (MRVI)?

  • 1 Month Returns

    -28.33%

  • 3 Months Returns

    -79.18%

  • 1 Year Returns

    -75.75%

  • 5 Years Returns

    -95.34%

Who is the Chief Executive Officer (CEO) of Maravai Lifesciences ?

Mr. William E. Martin III is the current Chief Executive Officer (CEO) of Maravai Lifesciences.